VALLON PHARMACEUTICALS INC (VLON)

US92023M1018 - Common Stock

0.4  -0.06 (-13.04%)

After market: 0.3901 -0.01 (-2.48%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.00100.00K0.000.00
Operating Expenses
6.93M9.26M4.89M3.15M4.31M
Research and Development
1.17M5.19M3.71M1.88M3.51M
Selling, General, and Administrative Expenses
5.76M4.07M1.18M1.27M800.00K
Operating Income
-6.93M-9.26M-4.79M-3.15M-4.31M
Interest Income/Expense
410.00K-105.00K-30.00K-310.00K0.00
Other Income/Expense
-506.00K61.00KN/AN/AN/A
Income Before Taxes
-7.02M-9.30M-4.82M-3.46M-4.31M
Net Income
-7.02M-9.30M-4.82M-3.46M-4.31M
EBITDA
-6.72M-9.17M-4.71M-3.13MN/A
 
Per Share Data
EPS Diluted Total Ops
-0.69-1.37-0.71-0.51-0.64
 
Statistics
Profit Margin
N/AN/A-4820.00%N/AN/A
Operating Profit Margin
N/AN/A-4790.00%N/AN/A

All data in USD

Charts